{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:50:22Z","timestamp":1792709422845,"version":"4.5.0"},"reference-count":209,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>This review summarizes the research on phospholipids and their use for drug delivery related to the Phospholipid Research Center Heidelberg (PRC). The focus is on projects that have been approved by the PRC since 2017 and are currently still ongoing or have recently been completed. The different projects cover all facets of phospholipid research, from basic to applied research, including the use of phospholipids in different administration forms such as liposomes, mixed micelles, emulsions, and extrudates, up to industrial application-oriented research. These projects also include all routes of administration, namely parenteral, oral, and topical. With this review we would like to highlight possible future research directions, including a short introduction into the world of phospholipids.<\/jats:p>","DOI":"10.3390\/pharmaceutics12121235","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T04:12:01Z","timestamp":1608523921000},"page":"1235","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["The Phospholipid Research Center: Current Research in Phospholipids and Their Use in Drug Delivery"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3272-1721","authenticated-orcid":false,"given":"Simon","family":"Drescher","sequence":"first","affiliation":[{"name":"Phospholipid Research Center, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van Hoogevest","sequence":"additional","affiliation":[{"name":"Phospholipid Research Center, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"IUPAC-IUB (1977). Nomenclature of phosphorus-containing compounds of biochemical importance (Recommendations1976). Proc. Natl. Acad. Sci. USA, 74, 2222\u20132230.","DOI":"10.1073\/pnas.74.6.2222"},{"key":"ref_2","unstructured":"Cevc, G. (1993). Phospholipids Handbook, Taylor & Francis Inc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/mp200479f","article-title":"Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of danazol across Caco-2 cell monolayers","volume":"9","author":"Vertzoni","year":"2012","journal-title":"Mol. Pharm."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hanin, I., and Pepeu, G. (1990). Phospholipids. Biochemical, Pharmaceutical, and Analytical Considerations, Plenum Press.","DOI":"10.1007\/978-1-4757-1364-0"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.3390\/molecules14125367","article-title":"Role of phosphatidyl-serine in bone repair and its technological exploitation","volume":"14","author":"Merolli","year":"2009","journal-title":"Molecules"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0163-7827(03)00025-0","article-title":"Exposure of platelet membrane phosphatidylserine regulates blood coagulation","volume":"42","author":"Lentz","year":"2003","journal-title":"Prog. Lipid Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.cdd.4401168","article-title":"CD14-dependent clearance of apoptotic cells by human macrophages: The role of phosphatidylserine","volume":"10","author":"Devitt","year":"2003","journal-title":"Cell Death Differ."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"van Hoogevest, P., Tiemessen, H., Metselaar, J.M., Drescher, S., and Fahr, A. (2021). The Use of Phospholipids to make Pharmaceutical Form Line Extensions. Eur. J. Lipid Sci. Technol., revision submitted.","DOI":"10.1002\/ejlt.202000297"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/ejlt.201400219","article-title":"The use of natural and synthetic phospholipids as pharmaceutical excipients","volume":"116","author":"Wendel","year":"2014","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2017.07.008","article-title":"Review\u2014An update on the use of oral phospholipid excipients","volume":"108","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_11","first-page":"1104","article-title":"Recent Advances in the Use of Phospholipid Excipients in Local or Injectable Depot Formulations","volume":"8","author":"Luciani","year":"2018","journal-title":"Pharm. Ind."},{"key":"ref_12","first-page":"97","article-title":"Phospholipids in Cosmetic Carriers (Phospholipids, Liposomes, Emulsions, Lamellar structures, Solubilizers, Biocompatibility)","volume":"Volume 6","author":"Cornier","year":"2019","journal-title":"Nanocosmetics\u2014From Ideas to Products"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1900411","DOI":"10.1002\/ejlt.201900411","article-title":"Non-Aqueous Phospholipid Concentrates for Increasing the Bioavailability of Poorly Soluble Compounds","volume":"122","year":"2020","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"ref_14","unstructured":"PRC (2020, August 13). Phospholipid Research Center (The PRC\u2014Vision and Mission). Available online: https:\/\/www.phospholipid-institute.com\/about\/the-prc\/."},{"key":"ref_15","unstructured":"PRC (2020, August 18). Phospholipid Research Center (Funded Projects). Available online: https:\/\/www.phospholipid-institute.com\/funding\/funded-projects\/."},{"key":"ref_16","unstructured":"(2020, December 16). Analytical Data; Lipoid GmbH: Ludwigshafen, Germany. Available online: https:\/\/www.lipoid.com\/en\/headquarter-and-manufacturing."},{"key":"ref_17","unstructured":"(2020, December 16). Phospholipid Research Center, Analytics Newsletter, Number 1. Egg Lecithins for Pharmaceutical Application; Heidelberg, Germany, Available online: https:\/\/www.phospholipid-research-center.com\/contact\/contact-person\/."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/0024-3205(82)90455-6","article-title":"Stability of small unilamellar liposomes in serum and clearance from the circulation: The effect of the phospholipid and cholesterol components","volume":"30","author":"Senior","year":"1982","journal-title":"Life Sci."},{"key":"ref_19","first-page":"213","article-title":"Chemical Reactions of Phosphatides","volume":"Volume 1","author":"Szuhaj","year":"1985","journal-title":"Lecithins"},{"key":"ref_20","unstructured":"Gunstone, F.D. (2012). Chapter 3\u2014Enzymatic modification of phospholipids. Phospholipid Technology and Applications, Woodhead Publishing."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0163-7827(94)90028-0","article-title":"Strategies for the synthesis of glycerophospholipids","volume":"33","author":"Paltauf","year":"1994","journal-title":"Prog. Lipid Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nano.2005.06.004","article-title":"Role of nanotechnology in targeted drug delivery and imaging: A concise review","volume":"1","author":"Koo","year":"2005","journal-title":"Nanomedicine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/js990006q","article-title":"O-ethylphosphatidylcholine: A metabolizable cationic phospholipid which is a serum-compatible DNA transfection agent","volume":"88","author":"MacDonald","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ange.19840960404","article-title":"Phospholipide als funktionelle Bausteine biologischer Membranen","volume":"96","author":"Eibl","year":"1984","journal-title":"Angew. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1248\/cpb.33.572","article-title":"An enantioselective synthesis of platelet-activating factors, their enantiomers, and their analogues from D- and L-tartaric acids","volume":"33","author":"Ohno","year":"1985","journal-title":"Chem. Pharm. Bull."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0009-3084(80)90034-1","article-title":"Synthesis of monoacid 2,3-diacyl-sn-glycerols via 1,6-ditrityl-d-mannitol","volume":"27","author":"Virtanen","year":"1980","journal-title":"Chem. Phys. Lipids"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1021\/ja00310a045","article-title":"Glycerol Kinase: Synthesis of Dihydroxyacetone Phosphate, sn-Glycerol-3-Phosphate, and Chiral Analogues","volume":"107","author":"Crans","year":"1985","journal-title":"J. Am. Chem. Soc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0022-2275(20)41674-8","article-title":"An improved method for the preparation of unsaturated phosphatidylcholines: Acylation of sn-glycero-3-phosphorylcholine in the presence of sodium methylsulfinylmethide","volume":"18","author":"Warner","year":"1977","journal-title":"J. Lipid Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ange.19780900718","article-title":"Einfaches Verfahren zur Veresterung von Carbons\u00e4uren","volume":"90","author":"Neises","year":"1978","journal-title":"Angew. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bpj.2013.12.034","article-title":"Detailed Comparison of Deuterium Quadrupole Profiles between Sphingomyelin and Phosphatidylcholine Bilayers","volume":"106","author":"Yasuda","year":"2014","journal-title":"Biophys. J."},{"key":"ref_31","unstructured":"Kirk, R.E., and Othmer, D.F. (1995). Kirk-Othmer Encyclopedia of Chemical Technology, John Wiley & Sons."},{"key":"ref_32","unstructured":"WHO (2020, August 13). WHO Food Additives Series No. 5. Available online: http:\/\/www.inchem.org\/documents\/jecfa\/jecmono\/v05je42.htm."},{"key":"ref_33","unstructured":"EMA (2020, August 13). COMMISSION REGULATION (EU) No 231\/2012 of 9 March 2012 Laying down Specifications for Food Additives Listed in Annexes II and III to Regulation (EC) No 1333\/2008 of the European Parliament and of the Council European Commission. Available online: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=celex:32012R0231."},{"key":"ref_34","unstructured":"(2020, August 20). Publications Office of the EU (Report from the Commission on Dietary Food Additive Intake in the European Union). Available online: https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/26105dba-6d8f-4515-a641-0e43fe3f5498\/language-en."},{"key":"ref_35","unstructured":"FDA (2020, August 20). 21CFR184.1400, Available online: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=184.1400."},{"key":"ref_36","unstructured":"FDA (2020, August 20). 21CFR184.1063, Available online: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=184.1063."},{"key":"ref_37","first-page":"19","article-title":"Egg allergy: An emerging foodborne problem","volume":"2","author":"Singh","year":"2014","journal-title":"J. Foodborne Zoonotic Dis."},{"key":"ref_38","unstructured":"Warner, J., and Meyer, R. (2020, August 10). SoyaAllergy: The Facts (PDF File). Available online: https:\/\/www.allergywise.org.uk\/wp-content\/uploads\/2017\/12\/Soya.pdf."},{"key":"ref_39","unstructured":"(2020, December 16). Analytical Data; Phospholipid GmbH: Cologne, Germany. Available online: https:\/\/www.lipoid.com\/en\/headquarter-and-manufacturing."},{"key":"ref_40","unstructured":"(2020, December 16). Study of the Allergenicity and Protein Content in Egg Lecithin; IFP Institut f\u00fcr Produktqualit\u00e4t: Berlin, Germany. Available online: https:\/\/www.produktqualitaet.com\/de\/."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/anae.14693","article-title":"Propofol use in children with allergies to egg, peanut, soybean or other legumes","volume":"74","author":"Sommerfield","year":"2019","journal-title":"Anaesthesia"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-010-0130-x","article-title":"Phospholipids and Lipid-Based Formulations in Oral Drug Delivery","volume":"27","author":"Fricker","year":"2010","journal-title":"Pharm. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1773-2247(11)50001-2","article-title":"Role of phospholipids in the oral and parenteral delivery of poorly water soluble drugs","volume":"21","author":"Liu","year":"2011","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"ref_44","unstructured":"Lipoid (2020, August 10). (Products). Available online: https:\/\/www.lipoid.com\/en\/node\/10."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s11095-006-9092-4","article-title":"Lipid injectable emulsions: Pharmacopeial and safety issues","volume":"23","author":"Driscoll","year":"2006","journal-title":"Pharm. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/0975-8453.59509","article-title":"Nanoemulsion: A pharmaceutical review","volume":"1","author":"Shah","year":"2013","journal-title":"Syst. Rev. Pharm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0939-6411(98)00037-X","article-title":"Increasing drug solubility by means of bile salt-phosphatidylcholine-based mixed micelles","volume":"46","author":"Hammad","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1164\/ajrccm.155.4.9105072","article-title":"Bovine surfactant therapy for patients with acute respiratory distress syndrome","volume":"155","author":"Gregory","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_49","first-page":"179","article-title":"Tobramycin administered by the TOBI\u00ae Podhaler\u00ae for persons with cystic fibrosis: A review","volume":"4","author":"Vandevanter","year":"2011","journal-title":"Med. Devices (Auckl.)"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u2014The first FDA-approved nano-drug: Lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2019.12.023","article-title":"The role of liposomes in clinical nanomedicine development. What now? Now what?","volume":"318","author":"Crommelin","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_52","first-page":"691","article-title":"Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors","volume":"51","author":"Drummond","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.2174\/092986709789712916","article-title":"Liposome-Encapsulated Anticancer Drugs: Still Waiting for the Magic Bullet?","volume":"16","author":"Fanciullino","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"ref_54","first-page":"4387","article-title":"Thermosensitive liposomal drug delivery systems: State of the art review","volume":"9","author":"Kneidl","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejpb.2018.09.010","article-title":"Thermosensitive liposomes for triggered release of cytotoxic proteins","volume":"132","author":"Beztsinna","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2013.01.009","article-title":"Ultrasonic gene and drug delivery using eLiposomes","volume":"167","author":"Javadi","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3389\/fphar.2019.01463","article-title":"Ultrasound-Sensitive Liposomes for Triggered Macromolecular Drug Delivery: Formulation and in Vitro Characterization","volume":"10","author":"Deckers","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1021\/acs.molpharmaceut.6b00207","article-title":"Indocyanine Green-Loaded Liposomes for Light-Triggered Drug Release","volume":"13","author":"Lajunen","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jconrel.2018.06.029","article-title":"The effect of light sensitizer localization on the stability of indocyanine green liposomes","volume":"284","author":"Lajunen","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/1061186X.2015.1052072","article-title":"Hyaluronic acid targeting of CD44 for cancer therapy: From receptor biology to nanomedicine","volume":"23","author":"Mattheolabakis","year":"2015","journal-title":"J. Drug Target."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kari, O.K., Tavakoli, S., Parkkila, P., Baan, S., Savolainen, R., Ruoslahti, T., Johansson, N.G., Ndika, J., Alenius, H., and Viitala, T. (2020). Light-Activated Liposomes Coated with Hyaluronic Acid as a Potential Drug Delivery System. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12080763"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.nano.2013.04.007","article-title":"Photoactivation of gold nanoparticles for glioma treatment","volume":"9","author":"Bobyk","year":"2013","journal-title":"Nanomedicine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2001675","DOI":"10.1002\/advs.202001675","article-title":"Radiation Dose-Enhancement Is a Potent Radiotherapeutic Effect of Rare-Earth Composite Nanoscintillators in Preclinical Models of Glioblastoma","volume":"7","author":"Bulin","year":"2020","journal-title":"Adv. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/09298673113209990211","article-title":"Development and in vitro proof-of-concept of interstitially targeted zinc-phthalocyanine liposomes for photodynamic therapy","volume":"21","author":"Broekgaarden","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"18657","DOI":"10.1039\/C8NR05299A","article-title":"Elemental and optical imaging evaluation of zwitterionic gold nanoclusters in glioblastoma mouse models","volume":"10","author":"Henry","year":"2018","journal-title":"Nanoscale"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1039\/D0NR01138J","article-title":"Surface functionalization of gold nanoclusters with arginine: A trade-off between microtumor uptake and radiotherapy enhancement","volume":"12","author":"Broekgaarden","year":"2020","journal-title":"Nanoscale"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1021\/acs.nanolett.9b00859","article-title":"Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia?","volume":"19","author":"Obaid","year":"2019","journal-title":"Nano Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nnano.2012.84","article-title":"Shear-stress sensitive lenticular vesicles for targeted drug delivery","volume":"7","author":"Holme","year":"2012","journal-title":"Nat. Nanotechnol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1016\/j.tetlet.2010.07.140","article-title":"The synthesis of 1,3-diamidophospholipids","volume":"51","author":"Fedotenko","year":"2010","journal-title":"Tetrahedron Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1021\/la5041745","article-title":"Bilayer Properties of 1,3-Diamidophospholipids","volume":"31","author":"Weinberger","year":"2015","journal-title":"Langmuir"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Li, X., Che, Z., Mazhar, K., Price, T.J., and Qin, Z. (2017). Ultrafast Near-Infrared Light-triggered Intracellular Uncaging to Probe Cell Signaling. Adv. Funct. Mater., 27.","DOI":"10.1002\/adfm.201605778"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1002\/anie.201915296","article-title":"Near-infrared Light Triggered-release in Deep Brain Regions Using Ultra-photosensitive Nanovesicles","volume":"59","author":"Xiong","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00540-018-2514-8","article-title":"The history and progress of local anesthesia: Multiple approaches to elongate the action","volume":"32","author":"Tobe","year":"2018","journal-title":"J. Anesth."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2217\/pmt-2018-0025","article-title":"Externally triggered patient-controlled local anesthesia","volume":"8","author":"Cullion","year":"2018","journal-title":"Pain Manag."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/17425247.2018.1517747","article-title":"Clinical translation of immunoliposomes for cancer therapy: Recent perspectives","volume":"15","author":"Wang","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.02.040","article-title":"Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities","volume":"277","author":"Belfiore","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.plipres.2004.12.001","article-title":"Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release","volume":"44","author":"Andresen","year":"2005","journal-title":"Prog. Lipid Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1359-0294(00)00090-X","article-title":"Liposome application: Problems and prospects","volume":"6","author":"Barenholz","year":"2001","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7555\/JBR.32.20180087","article-title":"Hepatic ischemia-reperfusion injury in liver transplant setting: Mechanisms and protective strategies","volume":"33","author":"Rampes","year":"2019","journal-title":"J. Biomed. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11095-014-1447-7","article-title":"Superoxide dismutase enzymosomes: Carrier capacity optimization, in vivo behaviour and therapeutic activity","volume":"32","author":"Corvo","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejps.2017.09.008","article-title":"Therapeutic activity of superoxide dismutase-containing enzymosomes on rat liver ischaemia-reperfusion injury followed by magnetic resonance microscopy","volume":"109","author":"Marcelino","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fonc.2018.00049","article-title":"Targeting Macrophages in Cancer: From Bench to Bedside","volume":"8","author":"Poh","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Binnemars-Postma, K.A., Storm, G., and Prakash, J. (2017). Nanomedicine Strategies to Target Tumor-Associated Macrophages. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050979"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1096\/fj.201700629R","article-title":"Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer","volume":"32","author":"Bansal","year":"2018","journal-title":"FASEB J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2019.06.025","article-title":"Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells","volume":"307","author":"Poley","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1021\/acsnano.9b02395","article-title":"Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors","volume":"13","author":"Zinger","year":"2019","journal-title":"ACS Nano"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.01.004","article-title":"Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin","volume":"296","author":"Koren","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11764-016-0556-1","article-title":"Long-term functional outcomes and quality of life in adult survivors of childhood extremity sarcomas: A report from the St. Jude Lifetime Cohort Study","volume":"11","author":"Hudson","year":"2017","journal-title":"J. Cancer Surviv."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Hajdin, K., D\u2019Alessandro, V., Niggli, F.K., Sch\u00e4fer, B.W., and Bernasconi, M. (2010). Furin Targeted Drug Delivery for Treatment of Rhabdomyosarcoma in a Mouse Model. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010445"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2217\/nnm-2017-0430","article-title":"Prolonged circulation and increased tumor accumulation of liposomal vincristine in a mouse model of rhabdomyosarcoma","volume":"12","author":"Roveri","year":"2017","journal-title":"Nanomedicine (Lond. UK)"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1039\/C7TB00318H","article-title":"Peptides for tumor-specific drug targeting: State of the art and beyond","volume":"5","author":"Roveri","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Alijaj, N., Moutel, S., Gouveia, Z.L., Gray, M., Roveri, M., Dzhumashev, D., Weber, F., Meier, G., Luciani, P., and Rossler, J.K. (2020). Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma. Cancers, 12.","DOI":"10.3390\/cancers12113313"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0051-2","article-title":"Rhabdomyosarcoma","volume":"5","author":"Skapek","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1158\/2326-6066.CIR-18-0277","article-title":"T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection","volume":"6","author":"Trujillo","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-15-1399","article-title":"Dendritic Cell-Based Immunotherapy: State of the Art and Beyond","volume":"22","author":"Bol","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/j.1460-2075.1991.tb07689.x","article-title":"Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages","volume":"10","author":"Crocker","year":"1991","journal-title":"EMBO J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.celrep.2018.01.021","article-title":"Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8(+) T Cell Cross-Priming","volume":"22","author":"Veninga","year":"2018","journal-title":"Cell Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrn.2017.29","article-title":"Not just amyloid: Physiological functions of the amyloid precursor protein family","volume":"18","author":"Deller","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2016.03.031","article-title":"A liposomal formulation for the oral application of the investigational hepatitis B drug Myrcludex B","volume":"103","author":"Uhl","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Siljander","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nantod.2015.04.004","article-title":"Cell-derived vesicles for drug therapy and diagnostics: Opportunities and challenges","volume":"10","author":"Fuhrmann","year":"2015","journal-title":"Nano Today"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Gould, S.J., and Raposo, G. (2013). As we wait: Coping with an imperfect nomenclature for extracellular vesicles. J. Extracell. Vesicles, 2.","DOI":"10.3402\/jev.v2i0.20389"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Valentino, G., Zivko, C., Weber, F., Br\u00fclisauer, L., and Luciani, P. (2019). Synergy of Phospholipid-Drug Formulations Significantly Deactivates Profibrogenic Human Hepatic Stellate Cells. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11120676"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Zivko, C., Fuhrmann, G., and Luciani, P. (2020). Liver-derived extracellular vesicles: A cell by cell overview to isolation and characterization practices. Biochim. Biophys. Acta Gen. Subj., 129559.","DOI":"10.1016\/j.bbagen.2020.129559"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","volume":"35","author":"Dowdy","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.biomaterials.2016.06.024","article-title":"RNAi delivery by exosome-mimetic nanovesicles\u2014Implications for targeting c-Myc in cancer","volume":"102","author":"Lunavat","year":"2016","journal-title":"Biomaterials"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ymthe.2017.03.021","article-title":"Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles","volume":"25","author":"Mager","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Hettich, B.F., Ben-Yehuda Greenwald, M., Werner, S., and Leroux, J.-C. (2020). Exosomes for Wound Healing: Purification Optimization and Identification of Bioactive Components. Adv. Sci., 2002596.","DOI":"10.1002\/advs.202002596"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"30087","DOI":"10.3402\/jev.v4.30087","article-title":"Applying extracellular vesicles based therapeutics in clinical trials\u2014An ISEV position paper","volume":"4","author":"Lener","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"21933","DOI":"10.1038\/srep21933","article-title":"Engineering hybrid exosomes by membrane fusion with liposomes","volume":"6","author":"Sato","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/acsnano.6b07607","article-title":"Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics","volume":"11","author":"Armstrong","year":"2017","journal-title":"ACS Nano"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1021\/acsnano.8b02053","article-title":"Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems","volume":"12","author":"Piffoux","year":"2018","journal-title":"ACS Nano"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"203102","DOI":"10.1088\/0953-8984\/21\/20\/203102","article-title":"Polyelectrolyte-induced aggregation of liposomes: A new cluster phase with interesting applications","volume":"21","author":"Bordi","year":"2009","journal-title":"J. Phys. Condens. Matter"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.nano.2010.10.003","article-title":"Multicompartment vectors as novel drug delivery systems: Selective activation of T\u03b3\u03b4 lymphocytes after zoledronic acid delivery","volume":"7","author":"Agrati","year":"2011","journal-title":"Nanomedicine"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.colsurfa.2015.12.024","article-title":"Phospholipid adsorption at oil in water versus water in oil interfaces: Implications for interfacial densities and bulk solubilities","volume":"505","author":"Hildebrandt","year":"2016","journal-title":"Colloids Surf. A"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/acs.langmuir.6b00978","article-title":"Interactions between Phospholipids and Organic Phases: Insights into Lipoproteins and Nanoemulsions","volume":"32","author":"Hildebrandt","year":"2016","journal-title":"Langmuir"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.colsurfa.2017.08.021","article-title":"Transfer of colloidal particles between two non-miscible liquid phases","volume":"535","author":"Sommerling","year":"2017","journal-title":"Colloids Surf. A"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/acs.langmuir.7b02852","article-title":"Instability Mechanisms of Water-in-Oil Nanoemulsions with Phospholipids: Temporal and Morphological Structures","volume":"34","author":"Sommerling","year":"2018","journal-title":"Langmuir"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1039\/C8SM00005K","article-title":"Adsorption of phospholipids at oil\/water interfaces during emulsification is controlled by stress relaxation and diffusion","volume":"14","author":"Hildebrandt","year":"2018","journal-title":"Soft Matter"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00396-020-04618-3","article-title":"Adsorption process for phospholipids of different chain lengths at a fluorocarbon\/water interface studied by Du No\u00fcy ring and spinning drop","volume":"298","author":"Ullmann","year":"2020","journal-title":"Colloid Polym. Sci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/1061186X.2019.1579819","article-title":"Liposomes with asymmetric bilayers produced from inverse emulsions for nucleic acid delivery","volume":"27","author":"Miranda","year":"2019","journal-title":"J. Drug Target."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2018.06.031","article-title":"Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis","volume":"155","author":"Musso","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: Emerging molecular targets and therapeutic strategies","volume":"15","author":"Musso","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"E6254","DOI":"10.1073\/pnas.1800544115","article-title":"Macrophage phenotype and bioenergetics are controlled by oxidized phospholipids identified in lean and obese adipose tissue","volume":"115","author":"Serbulea","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"ten Hove, M., Pater, L., Storm, G., Weiskirchen, S., Weiskirchen, R., Lammers, T., and Bansal, R. (2020). The hepatic lipidome: From basic science to clinical translation. Adv. Drug Deliv. Rev.","DOI":"10.1016\/j.addr.2020.06.027"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijpharm.2010.10.046","article-title":"Self-assembly nanoparticles for the delivery of bisphosphonates into tumors","volume":"403","author":"Salzano","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biotechadv.2011.06.018","article-title":"New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: A comparative study","volume":"30","author":"Marra","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1166\/jbn.2016.2214","article-title":"Transferrin-Targeted Nanoparticles Containing Zoledronic Acid as a Potential Tool to Inhibit Glioblastoma Growth","volume":"12","author":"Salzano","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"119693","DOI":"10.1016\/j.ijpharm.2020.119693","article-title":"Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA","volume":"588","author":"Campani","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1073\/pnas.1216182110","article-title":"Arachidonoyl-phosphatidylcholine oscillates during the cell cycle and counteracts proliferation by suppressing Akt membrane binding","volume":"110","author":"Koeberle","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1096\/fj.201700078R","article-title":"Vitamin A regulates Akt signaling through the phospholipid fatty acid composition","volume":"31","author":"Pein","year":"2017","journal-title":"FASEB J."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1194\/jlr.M080101","article-title":"Acetyl-CoA carboxylase 1 regulates endothelial cell migration by shifting the phospholipid composition","volume":"59","author":"Glatzel","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2017.07.017","article-title":"Saturated phosphatidylcholine as matrix former for oral extended release dosage forms","volume":"108","author":"Kolbina","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1208\/s12249-019-1366-3","article-title":"Evaluation of Hydrogenated Soybean Phosphatidylcholine Matrices Prepared by Hot Melt Extrusion for Oral Controlled Delivery of Water-Soluble Drugs","volume":"20","author":"Kolbina","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"102096","DOI":"10.1016\/j.nano.2019.102096","article-title":"Phosphatidylserine (PS) and phosphatidylglycerol (PG) nanodispersions as potential anti-inflammatory therapeutics: Comparison of in vitro activity and impact of pegylation","volume":"23","author":"Klein","year":"2020","journal-title":"Nanomedicine"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Zlomke, C., Albrecht, J., and M\u00e4der, K. (2020). Nicardipine Loaded Solid Phospholipid Extrudates for the Prevention of Cerebral Vasospasms: In Vitro Characterization. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12090817"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/sj.bjp.0707302","article-title":"Apoptotic mimicry: Phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivo","volume":"151","author":"Ramos","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.117.244756","article-title":"Soy Phosphatidylglycerol Reduces Inflammation in a Contact Irritant Ear Edema Mouse Model in Vivo","volume":"366","author":"Xie","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nutres.2013.01.006","article-title":"Phosphatidylserine inhibits inflammatory responses in interleukin-1\u03b2-stimulated fibroblast-like synoviocytes and alleviates carrageenan-induced arthritis in rat","volume":"33","author":"Yeom","year":"2013","journal-title":"Nutr. Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/02656736.2014.997809","article-title":"Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy","volume":"31","author":"Daeichin","year":"2015","journal-title":"Int. J. Hyperth."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2014.03.003","article-title":"Acoustic behavior of microbubbles and implications for drug delivery","volume":"72","author":"Kooiman","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ultrasmedbio.2020.01.002","article-title":"Ultrasound-Responsive Cavitation Nuclei for Therapy and Drug Delivery","volume":"46","author":"Kooiman","year":"2020","journal-title":"Ultrasound Med. Biol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.ultrasmedbio.2019.06.004","article-title":"Combined Confocal Microscope and Brandaris 128 Ultra-High-Speed Camera","volume":"45","author":"Beekers","year":"2019","journal-title":"Ultrasound Med. Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1021\/acs.langmuir.9b03912","article-title":"Ligand Distribution and Lipid Phase Behavior in Phospholipid-Coated Microbubbles and Monolayers","volume":"36","author":"Langeveld","year":"2020","journal-title":"Langmuir"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jcis.2016.08.067","article-title":"Optimization of lipodisk properties by modification of the extent and density of the PEG corona","volume":"484","author":"Zetterberg","year":"2016","journal-title":"J. Colloid Interface Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2019.02.009","article-title":"Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer","volume":"560","author":"Feng","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"22178","DOI":"10.1039\/C7RA04059H","article-title":"EGF-targeting lipodisks for specific delivery of poorly water-soluble anticancer agents to tumour cells","volume":"7","author":"Ahlgren","year":"2017","journal-title":"RSC Adv."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.nano.2017.06.020","article-title":"Targeting lipodisks enable selective delivery of anticancer peptides to tumor cells","volume":"13","author":"Ahlgren","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Lundsten, S., Hern\u00e1ndez, V.A., Gedda, L., Sar\u00e9n, T., Brown, C.J., Lane, D.P., Edwards, K., and Nestor, M. (2020). Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks. Nanomaterials, 10.","DOI":"10.3390\/nano10040783"},{"key":"ref_153","first-page":"E1183","article-title":"Intestinal lipid absorption","volume":"296","author":"Iqbal","year":"2009","journal-title":"Am. J. Physiol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1021\/cr030602b","article-title":"Bolaamphiphiles","volume":"104","author":"Fuhrhop","year":"2004","journal-title":"Chem. Rev."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cocis.2007.05.003","article-title":"Self-assembly of bipolar amphiphiles","volume":"12","author":"Meister","year":"2007","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijpharm.2010.12.005","article-title":"Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids","volume":"405","author":"Parmentier","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2011.05.066","article-title":"Oral peptide delivery by tetraether lipid liposomes","volume":"415","author":"Parmentier","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejps.2017.07.013","article-title":"Oral delivery of vancomycin by tetraether lipid liposomes","volume":"108","author":"Uhl","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejps.2016.12.036","article-title":"Archaeal lipids in oral delivery of therapeutic peptides","volume":"108","author":"Jacobsen","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Markowski, T., M\u00fcller, S., Dobner, B., Meister, A., Blume, A., and Drescher, S. (2017). An Asymmetrical Glycerol Diether Bolalipid with Protonable Phosphodimethylethanolamine Headgroup: The Impact of pH on Aggregation Behavior and Miscibility with DPPC. Polymers, 9.","DOI":"10.3390\/polym9110573"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1021\/acs.langmuir.8b00527","article-title":"Impact of Headgroup Asymmetry and Protonation State on the Aggregation Behavior of a New Type of Glycerol Diether Bolalipid","volume":"34","author":"Drescher","year":"2018","journal-title":"Langmuir"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1039\/C8OB00424B","article-title":"Synthesis and aggregation behaviour of single-chain, 1,32-alkyl branched bis(phosphocholines): Effect of lateral chain length","volume":"16","author":"Gruhle","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1039\/D0OB00534G","article-title":"Synthesis and aggregation behaviour of single-chain, 1,32-alkyl-branched bis(phosphocholines)\u2014Part 2: Lateral chain length triggers self-assembling from sheets to fibres to vesicles","volume":"18","author":"Gruhle","year":"2020","journal-title":"Org. Biomol. Chem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bpc.2018.04.005","article-title":"Mixing behaviour of asymmetrical glycerol diether bolalipids with saturated and unsaturated phosphatidylcholines","volume":"238","author":"Meister","year":"2018","journal-title":"Biophys. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bpc.2018.10.003","article-title":"Mixing behaviour of bilayer-forming phosphatidylcholines with single-chain alkyl-branched bolalipids: Effect of lateral chain length","volume":"244","author":"Kind","year":"2019","journal-title":"Biophys. Chem."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"M\u00fcller, S., Gruhle, K., Meister, A., Hause, G., and Drescher, S. (2019). Bolalipid-Doped Liposomes: Can Bolalipids Increase the Integrity of Liposomes Exposed to Gastrointestinal Fluids?. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11120646"},{"key":"ref_167","first-page":"1653","article-title":"Bile salt\/phospholipid mixed micelle precursor pellets prepared by fluid-bed coating","volume":"8","author":"Dong","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.2147\/DDDT.S119918","article-title":"Comparison of bile salt\/phosphatidylcholine mixed micelles in solubilization to sterols and stability","volume":"10","author":"Guo","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2147\/IJN.S56215","article-title":"Application of spray granulation for conversion of mixed phospholipid-bile salt micelles to dry powder form: Influence of drug hydrophobicity on nanoparticle reagglomeration","volume":"9","author":"Lv","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3109\/13880209.2013.872153","article-title":"Azadirachta indica extract\u2013artesunic acid combination produces an increased cure rate of Plasmodium berghei-infected mice","volume":"52","author":"Anagu","year":"2014","journal-title":"Pharm. Biol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/ejnm-2016-0009","article-title":"Solid lipid nanoparticles encapsulating a fluorescent marker (coumarin 6) and antimalarials\u2014Artemether and lumefantrine: Evaluation of cellular uptake and antimalarial activity","volume":"8","author":"Attama","year":"2016","journal-title":"Eur. J. Nanomed."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejps.2015.04.001","article-title":"Preparation, characterization and in vivo studies of amorphous solid dispersion of berberine with hydrogenated phosphatidylcholine","volume":"74","author":"Shi","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejps.2015.08.005","article-title":"Phospholipid-based solid drug formulations for oral bioavailability enhancement: A meta-analysis","volume":"80","author":"Fong","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-3549(15)00186-0","article-title":"Solid Phospholipid Dispersions for Oral Delivery of Poorly Soluble Drugs: Investigation into Celecoxib Incorporation and Solubility-in Vitro Permeability Enhancement","volume":"105","author":"Fong","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejps.2016.05.023","article-title":"Molecular insights into the formation of drug-monoacyl phosphatidylcholine solid dispersions for oral delivery","volume":"108","author":"Gautschi","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejps.2018.11.003","article-title":"A dynamic in vitro permeation study on solid mono- and diacyl-phospholipid dispersions of celecoxib","volume":"127","author":"Jacobsen","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/jps.23640","article-title":"Preparation and characterization of insulin-surfactant complexes for loading into lipid-based drug delivery systems","volume":"102","author":"Li","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijpharm.2014.10.039","article-title":"Self-nanoemulsifying drug delivery systems for oral insulin delivery: In vitro and in vivo evaluations of enteric coating and drug loading","volume":"477","author":"Li","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ejpb.2013.12.017","article-title":"The role of citric acid in oral peptide and protein formulations: Relationship between calcium chelation and proteolysis inhibition","volume":"86","author":"Welling","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijpharm.2019.02.014","article-title":"SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2\/HT29 co-culture monolayers and intra-jejunal instillation in rats","volume":"560","author":"Liu","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"105272","DOI":"10.1016\/j.ejps.2020.105272","article-title":"Evaluation of self-emulsifying drug delivery systems for oral insulin delivery using an in vitro model simulating the intestinal proteolysis","volume":"147","author":"Liu","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1208\/s12248-014-9674-8","article-title":"Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: A systematic study based on a quality by design approach","volume":"17","author":"Patil","year":"2015","journal-title":"AAPS J."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/acs.molpharmaceut.8b00920","article-title":"Modified Polymer Matrix in Pharmaceutical Hot Melt Extrusion by Molecular Interactions with a Carboxylic Coformer","volume":"16","author":"Ditzinger","year":"2019","journal-title":"Mol. Pharm."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1773-2247(11)50006-1","article-title":"Lecithin-based nanoemulsions","volume":"21","author":"Klang","year":"2011","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s11095-012-0899-x","article-title":"Lecithin-Based Microemulsions for Targeted Delivery of Ceramide AP into the Stratum Corneum: Formulation, Characterizations, and In Vitro Release and Penetration Studies","volume":"30","author":"Sahle","year":"2013","journal-title":"Pharm. Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijpharm.2015.05.042","article-title":"LeciPlex, invasomes, and liposomes: A skin penetration study","volume":"490","author":"Shah","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijpharm.2015.08.059","article-title":"Design of lipid microparticle dispersions based on the physicochemical properties of the lipid and aqueous phase","volume":"494","author":"Lauterbach","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jddst.2017.08.016","article-title":"Monoacyl-phosphatidylcholine nanostructured lipid carriers: Influence of lipid and surfactant content on in vitro skin permeation of flufenamic acid and fluconazole","volume":"41","author":"Wolf","year":"2017","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Ebeling, S., Naumann, K., Pollok, S., Wardecki, T., Vidal, Y.S.S., Nascimento, J.M., Boerries, M., Schmidt, G., Brandner, J.M., and Merfort, I. (2014). From a traditional medicinal plant to a rational drug: Understanding the clinically proven wound healing efficacy of birch bark extract. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086147"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1055\/a-0850-0224","article-title":"The Wound Healing Properties of Betulin from Birch Bark from Bench to Bedside","volume":"85","author":"Scheffler","year":"2019","journal-title":"Planta Med."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/jps.21210","article-title":"Wound healing dressings and drug delivery systems: A review","volume":"97","author":"Boateng","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/pat.1625","article-title":"A review on wound dressings with an emphasis on electrospun nanofibrous polymeric bandages","volume":"21","author":"Zahedi","year":"2010","journal-title":"Polym. Adv. Technol."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Mwiiri, F.K., and Daniels, R. (2020). Optimized Birch Bark Extract-Loaded Colloidal Dispersion Using Hydrogenated Phospholipids as Stabilizer. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12090832"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Mwiiri, F.K., Brandner, J.M., and Daniels, R. (2020). Electrospun Bioactive Wound Dressing Containing Colloidal Dispersions of Birch Bark Dry Extract. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12080770"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijpharm.2019.05.078","article-title":"Cytotoxicity of lecithin-based nanoemulsions on human skin cells and ex vivo skin permeation: Comparison to conventional surfactant types","volume":"566","author":"Vater","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"119209","DOI":"10.1016\/j.ijpharm.2020.119209","article-title":"Effects of lecithin-based nanoemulsions on skin: Short-time cytotoxicity MTT and BrdU studies, skin penetration of surfactants and additives and the delivery of curcumin","volume":"580","author":"Vater","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/09546634.2015.1021663","article-title":"Triterpenes with healing activity: A systematic review","volume":"26","author":"Agra","year":"2015","journal-title":"J. Dermatol. Treat."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/wound.2013.0492","article-title":"Refined Spruce Resin to Treat Chronic Wounds: Rebirth of an Old Folkloristic Therapy","volume":"5","author":"Jokinen","year":"2016","journal-title":"Adv. Wound Care (New Rochelle)"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.colsurfa.2018.08.037","article-title":"Physicochemical characterization of natural phospholipid excipients with varying PC content","volume":"558","author":"Otto","year":"2018","journal-title":"Colloids Surf. A"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejps.2016.12.002","article-title":"Sucrose esters as biocompatible surfactants for penetration enhancement: An insight into the mechanism of penetration enhancement studied using stratum corneum model lipids and Langmuir monolayers","volume":"99","author":"Brezesinski","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1038\/ncomms10447","article-title":"Octanol-assisted liposome assembly on chip","volume":"7","author":"Deshpande","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nprot.2017.160","article-title":"On-chip microfluidic production of cell-sized liposomes","volume":"13","author":"Deshpande","year":"2018","journal-title":"Nat. Protoc."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1039\/C8LC00932E","article-title":"A microfluidic platform for the characterisation of membrane active antimicrobials","volume":"19","author":"Cama","year":"2019","journal-title":"Lab Chip"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Bossa, G.V., Gunderson, S., Downing, R., and May, S. (2019). Role of Transmembrane Proteins for Phase Separation and Domain Registration in Asymmetric Lipid Bilayers. Biomolecules, 9.","DOI":"10.3390\/biom9080303"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1039\/D0SM00499E","article-title":"Saddle-curvature instability of lipid bilayer induced by amphipathic peptides: A molecular model","volume":"16","author":"Downing","year":"2020","journal-title":"Soft Matter"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"054707","DOI":"10.1063\/1.5138192","article-title":"Influence of spontaneous curvature on the line tension of phase-coexisting domains in a lipid monolayer: A Landau-Ginzburg model","volume":"152","author":"Downing","year":"2020","journal-title":"J. Chem. Phys."},{"key":"ref_207","unstructured":"EMA (2020, October 16). Reflection Paper on the Pharmaceutical Development of Intravenous Medicinal Products Containing Active Substances Solubilised in Micellar Systems. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/reflection-paper-pharmaceutical-development-intravenous-medicinal-products-containing-active_en.pdf."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.colsurfb.2018.02.023","article-title":"Study on the in situ aggregation of liposomes with negatively charged phospholipids for use as injectable depot formulation","volume":"168","author":"Rahnfeld","year":"2018","journal-title":"Colloids Surf. B"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Rahnfeld, L., and Luciani, P. (2020). Injectable Lipid-Based Depot Formulations: Where Do We Stand?. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12060567"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/12\/12\/1235\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:47:16Z","timestamp":1760179636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/12\/12\/1235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"references-count":209,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["pharmaceutics12121235"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics12121235","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,18]]}}}